# RHD Genotype Matched Red Cells for Anti-D

> **NCT04156906** · EARLY_PHASE1 · COMPLETED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 5 (actual)

## Conditions studied

- Sickle Cell Disease
- Anti-D Antibodies

## Interventions

- **BIOLOGICAL:** D+ RH genotype matched red cell units for transfusion

## Key facts

- **NCT ID:** NCT04156906
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-08
- **Primary completion:** 2024-03-04
- **Final completion:** 2024-10-04
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2025-05-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04156906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04156906, "RHD Genotype Matched Red Cells for Anti-D". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04156906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*